No Significant Difference in Asthma Control Across Three Approaches to Adjust … – eNews Park Forest

No Significant Difference in Asthma Control Across Three Approaches to Adjust
eNews Park Forest
A study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma has found no detectable differences in how often a person's asthma worsened. The methods examined in this study

View full post on asthma – Google News

Study Proposes New Way to Control Asthma – Post News Group


CBS News

Study Proposes New Way to Control Asthma
Post News Group
For two decades, asthma treatment for millions of people with a milder form of the disease has consisted of daily inhaled steroid medicine to reduce inflammation. Now, a new study has found that asthmatics who take the low-dose medication as a daily
Mild asthmatics may not need daily steroid use according to a new studyNew York Daily News
Mild-to-moderate asthma sufferers may not benefit from daily dose of steroidsCBS News
Mild asthma patients 'may not need daily steroids'Pakistan Observer
U.S. News & World Report –allvoices –ABC News (blog)
all 98 news articles »

View full post on asthma – Google News

No significant difference in asthma control across three approaches to adjust … – Pharmaceutical Processing

No significant difference in asthma control across three approaches to adjust
Pharmaceutical Processing
A study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma has found no detectable differences in how often a person's asthma worsened. The methods examined in this study

and more »

View full post on asthma – Google News

Take Control of Asthma This School Year – Gonzales Inquirer

Take Control of Asthma This School Year
Gonzales Inquirer
(NewsUSA) – If your child has asthma, add this to your checklist: a written asthma action plan from your child's health care provider. "For 7 million children in the U.S., asthma is a lifelong disease that requires daily care. But with proper treatment
American Lung Association of the Upper Midwest And Health Care Service The Herald | HeraldOnline.com

all 7 news articles »

View full post on asthma – Google News

Take Control of Asthma This School Year – Inside Tucson Business

Take Control of Asthma This School Year
Inside Tucson Business
"For 7 million children in the U.S., asthma is a lifelong disease that requires daily care. But with proper treatment, most children who have asthma can spend as much time in the classroom, or being physically active, as those who do not have asthma
Childhood Asthma Leadership Coalition Launchesnews Stories

all 13 news articles »

View full post on asthma – Google News

Take Control of Asthma This School Year – The Southeast Sun

Take Control of Asthma This School Year
The Southeast Sun
"For 7 million children in the U.S., asthma is a lifelong disease that requires daily care. But with proper treatment, most children who have asthma can spend as much time in the classroom, or being physically active, as those who do not have asthma
Childhood Asthma Leadership Coalition Launchesnews Stories

all 7 news articles »

View full post on asthma – Google News

Therapeutical Measures to Control Airway Tolerance in Asthma and Lung Cancer.

Related Articles

Therapeutical Measures to Control Airway Tolerance in Asthma and Lung Cancer.

Front Immunol. 2012;3:216

Authors: Andreev K, Graser A, Maier A, Mousset S, Finotto S

Abstract
Airway tolerance is a specialized immunological surveillance which is activated by the cells of the lung to deal with and distinguish between innocuous and pathogenic inhalants. However, this distinction does not always occur. Airway tolerance is necessary to avoid the development of allergic disorders, such as asthma, which is dominated by a pathological expansion of Th2 and Th17 cells in the airways. By contrast, tumor cells induce tolerogenic factors in their microenvironment to evade T-cell mediated anti-tumor-immune responses. This review updates current understandings on the effect of the cytokines TGF-?, IL-10, and IL-17A on the lung immune responses to antigen, and analyzes their involvement in allergic asthma and lung cancer. The aim of the review is to evaluate where therapeutic intervention may be feasible and where it might fail. The multifunctional role of these cytokines further complicates the decision on the timing and concentration for their use as therapeutical targets. In fact, TGF-? has suppressive activity in early tumorigenesis, but may become tumor-promoting in the later stages of the disease. This dual behavior is sometimes due to changes in the cellular target of TGF-?, and to the expansion of the induced (i)-Tregs. Similarly, IL-17A has been found to elicit pro- as well as anti-tumor properties. Thus, this pro-inflammatory cytokine induces the production of IL-6 which interferes with Treg development. Yet IL-17A could promote tumor growth in conjunction with IL-6-dependent activation of Stat3. Thus, understanding the mechanisms of airway tolerance could help to improve the therapy to both, allergic asthma and lung cancer. Hereby, asthma therapy aims to induce and maintain tolerance to inhaled allergens and therapy against lung cancer tries to inhibit the tolerogenic response surrounding the tumor.

PMID: 22855687 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Ford Sync Voice Control now supports Allergy Alert App – SlashGear


SlashGear

Ford Sync Voice Control now supports Allergy Alert App
SlashGear
The Allergy Alert app allows drivers to get the current forecast for allergens, pollen, asthma, flu, and UV conditions while driving. Knowing what sort of allergens are in the air in a strange location is a big deal for drivers who suffer from asthma
Allergy Alert App Added to Ford Sync AppLinkPC Magazine
Allergy Alert app now compatible with Ford SYNC AppLinkNerd Reactor
Ford Enables SYNC Voice Control of Allergy Alert App by IMS Health Giving Equities.com

all 16 news articles »

View full post on asthma – Google News